Displaying drugs 201 - 225 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Insulin glargine | 6063.0 C267H404N72O78S6 |  | A modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Hypolipidemic Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin detemir | 5916.9 C267H402N64O76S6 |  | A long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Blood Glucose Lowering Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin degludec | 6103.97 C274H411N65O81S6 |  | A long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus. | Insulin Analog |
| Insulin beef | C254H377N65O75S6 |  | Insulin beef has been discontinued in the US and Canada since 2017. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin aspart | 5825.8 C256H381N65O79S6 |  | A rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Inotuzumab ozogamicin | Not Available | | An antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL). | Antibodies, Monoclonal / CD22 (Clusters of Differentiation 22) inhibitors |
| Infliximab | 144190.3 C6428H9912N1694O1987S46 |  | A monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Inebilizumab | 149000.0 | | A humanized anti-CD19 cytolytic monoclonal antibody for B-cell depletion in autoimmune conditions. Currently approved only for neuromyelitis optica spectrum disorder (NMOSD). | Selective Immunosuppressants |
| Imlifidase | C1575H2400N422O477S6 | | A cysteine protease that specifically cleaves human IgG antibodies, facilitating kidney transplantation in HLA sensitized patients. | Selective Immunosuppressants |
| Imiglucerase | 55597.4 C2532H3854N672O711S16 |  | A form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. | Enzyme Replacement Therapy / Enzymes / Gaucher Disease / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme |
| Imdevimab | Not Available | | Part of an investigational recombinant monoclonal antibody cocktail used to treat mild to moderate COVID-19. | Antiviral monoclonal antibodies |
| Idursulfase | 76000.0 C2654H4000N688O774S14 | | A purified lysosomal enzyme used as a replacement therapy for Hunter syndrome in pediatric and adult patients. | Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Idarucizumab | Not Available |  | An antibody that binds dabigatran for the reversal of anticoagulant effects of dabigatran. | Antidotes |
| Icatibant | 1304.54 C59H89N19O13S | | A bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE). | Drugs Used in Hereditary Angioedema |
| Ibritumomab tiuxetan | 143375.5 C6382H9830N1672O1979S54 |  | A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. | Various Therapeutic Radiopharmaceuticals |
| Ibalizumab | Not Available | | A CD4-specific antibody used to treat HIV infections. | Anti-HIV Agents / CD4-directed Blocking Antibody / HIV Fusion Inhibitors / Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor |
| Hyaluronidase (ovine) | 53870.9 C2455H3775N617O704S21 |  | A purified form of sheep hyaluronidase enzyme used as an adjunct in subcutaneous rehydration therapy and to increase absorption of other drugs and radiopaque imaging agents. | Enzymes |
| Hyaluronidase (human recombinant) | 61000.0 | | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. | Glycoside Hydrolases |
| Hyaluronidase | Not Available | | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. | Enzymes |
| Human varicella-zoster immune globulin | Not Available | | A solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections. | Immunization, Passive |
| Human thrombin | Not Available |  | A platelet activating factor used to treat minor bleeding. | Blood Coagulation Factors |
| Human Rho(D) immune globulin | Not Available | | A solution of antibodies used to prevent isoimmunization of Rho(D) negative patients exposed to Rho(D) positive blood in pregnancy or transfusion. | Specific Immunoglobulins |
| Human interferon beta | 40036.0 | | A polypeptide drug used in the treatment of relapsing forms of Multiple Sclerosis (MS). | Immunologic Factors / Interferon Type I |
| Human immunoglobulin G | 142682.3 C6332H9826N1692O1980S42 |  | A purified form of human immunoglobulin G and other proteins used to treat immunodeficiency and a wide variety of autoimmune disorders. | Antibodies / Human Immunoglobulin G / Immunoglobulin G / Immunoglobulins / Immunologic Factors / Immunoproteins / Serum Globulins |
| Human cytomegalovirus immune globulin | Not Available | | A solution of immune globulin G against cytomegalovirus used to prevent transmission of cytomegalovirus after organ transplants. | Specific Immunoglobulins |
Displaying drugs 201 - 225 of 407 in total